89bio, Inc

-$0.25 (-1.46%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell 89bio, Inc and other ETFs, options, and stocks.

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases.

CEO
Rohan Palekar
Employees
27
Headquarters
San Francisco, California
Founded
2018

ETNB Key Statistics

Market Cap
399.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
90.41K
High Today
$17.31
Low Today
$16.49
Open Price
$17.19
Volume
46.29K
52 Week High
$42.36
52 Week Low
$15.52

ETNB Earnings

-$2.58
-$1.72
-$0.86
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure